195 related articles for article (PubMed ID: 2507222)
21. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
Hardy DJ
Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
[TBL] [Abstract][Full Text] [Related]
23. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
Sun ZM; Maskell JP; Sehgal SC; Williams JD
Infection; 1989; 17(3):165-7. PubMed ID: 2737760
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of clindamycin against strains of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum isolated from pregnant women.
Harrison HR; Riggin RM; Alexander ER; Weinstein L
Am J Obstet Gynecol; 1984 Jul; 149(5):477-80. PubMed ID: 6742014
[TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
[TBL] [Abstract][Full Text] [Related]
27. Mycoplasma hominis and Ureaplasma urealyticum in patients with sexually transmitted diseases.
Koch A; Bilina A; Teodorowicz L; Stary A
Wien Klin Wochenschr; 1997 Aug; 109(14-15):584-9. PubMed ID: 9286064
[TBL] [Abstract][Full Text] [Related]
28. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
Furneri PM; Bisignano G; Cerniglia G; Nicoletti G; Cesana M; Tempera G
Antimicrob Agents Chemother; 1994 Nov; 38(11):2651-4. PubMed ID: 7872762
[TBL] [Abstract][Full Text] [Related]
29. The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp.
Ridgway GL; Salman H; Robbins MJ; Dencer C; Felmingham D
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():31-4. PubMed ID: 9484871
[TBL] [Abstract][Full Text] [Related]
30. [Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].
Cao W; Liu L; Tong MH
Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):177-9. PubMed ID: 12934372
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases.
Limbert M; Seibert G; Winkler I; Isert D; Klesel N; Markus A; Schrinner E
J Antimicrob Chemother; 1992 Apr; 29 Suppl A():13-7. PubMed ID: 1318294
[TBL] [Abstract][Full Text] [Related]
32. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
Slaney L; Chubb H; Ronald A; Brunham R
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
[TBL] [Abstract][Full Text] [Related]
33. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Ureaplasma urealyticum infections using a novel isothermal simultaneous RNA amplification testing method in infertile males.
Qing L; Song QX; Feng JL; Li HY; Liu G; Jiang HH
Ann Clin Microbiol Antimicrob; 2017 Jun; 16(1):45. PubMed ID: 28646898
[TBL] [Abstract][Full Text] [Related]
35. Microbial causative agents of male urethritis.
Stefánik M; Rychna K; Valkoun A
J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):111-8. PubMed ID: 1619287
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
37. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
Torres JR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
Rumpianesi F; Morandotti G; Sperning R; Satta G; Cevenini R
J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of ofloxacin against Chlamydia trachomatis.
Schachter J; Moncada JV
Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
